Verana Health has acquired the technology assets and team from PYA Analytics, a large-scale data architecture solutions company, according to a press release.
In addition, the company completed $100 million in financing, led by GV and a host of new and existing investors.
Verana Health aggregates regulatory-grade data sets with the American Academy of Ophthalmology’s IRIS Registry and the American Academy of Neurology’s Axon Registry.
“Verana is assembling the most comprehensive data sets in medicine across multiple disease types with the goal of accelerating medical research
Uncategorized